139 related articles for article (PubMed ID: 8195324)
21. Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.
Sadilkova K; Dugaw K; Benjamin D; Jack RM
Clin Chim Acta; 2013 Sep; 424():253-7. PubMed ID: 23830883
[TBL] [Abstract][Full Text] [Related]
22. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous measurement of VMA and HVA in 24-hour urine samples.
Harr R
Clin Lab Sci; 1991; 4(4):237-41. PubMed ID: 10149424
[TBL] [Abstract][Full Text] [Related]
24. Determination of homovanillic acid and vanillylmandelic acid in neuroblastoma screening by stable isotope dilution GC-MS.
Fauler G; Leis HJ; Huber E; Schellauf C; Kerbl R; Urban C; Gleispach H
J Mass Spectrom; 1997 May; 32(5):507-14. PubMed ID: 9180052
[TBL] [Abstract][Full Text] [Related]
25. [Sensibility and specificity of N-myc oncogene with respect to other prognostic factors in 15 neuroblastomas].
Queizán A; García-Miguel P; Belló MJ; Castresana JC; Rey JA; Pestaña A
Cir Pediatr; 1995 Jul; 8(3):96-8. PubMed ID: 8527322
[TBL] [Abstract][Full Text] [Related]
26. Measurement of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) for diagnosis of neural crest tumors.
Sawada T
Pediatr Hematol Oncol; 1997; 14(4):291-3. PubMed ID: 9211532
[No Abstract] [Full Text] [Related]
27. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
Takeda T; Shimada M; Iizuka S; Takasugi N
Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
[TBL] [Abstract][Full Text] [Related]
28. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
[TBL] [Abstract][Full Text] [Related]
30. Analytical validation and clinical application of urinary vanillylmandelic acid and homovanillic acid by LC-MS/MS for diagnosis of neuroblastoma.
Shen Y; Li H; Lu J; Luo X; Guan Q; Cheng L
Biomed Chromatogr; 2019 Jun; 33(6):e4484. PubMed ID: 30632178
[TBL] [Abstract][Full Text] [Related]
31. Method of measurement of urinary homovanillic acid and vanillylmandelic acid by gas chromatography-mass spectrometry suitable for neuroblastoma screening.
Seviour JA; McGill AC; Dale G; Craft AW
J Chromatogr; 1988 Nov; 432():273-7. PubMed ID: 3220894
[No Abstract] [Full Text] [Related]
32. Cases of neuroblastoma missed by the mass screening programs.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J; Kawai T
Pediatr Res; 1989 Dec; 26(6):603-7. PubMed ID: 2602040
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of homovanillic acid (HVA) and vanillylmandelic acid (VMA) in urine using gas chromatography-mass spectrometry (GC/MS).
Allenbrand R; Garg U
Methods Mol Biol; 2010; 603():261-9. PubMed ID: 20077077
[TBL] [Abstract][Full Text] [Related]
34. Olive ingestion causing a false suspicion of relapsed neuroblastoma: A case of "oliveblastoma?".
Flynn N; LeFebvre A; Messahel B; Hogg SL
Pediatr Blood Cancer; 2018 Oct; 65(10):e27248. PubMed ID: 29923309
[TBL] [Abstract][Full Text] [Related]
35. Capillary gas-chromatographic determination of urinary homovanillic acid and vanillylmandelic acid.
Tuchman M; Crippin PJ; Krivit W
Clin Chem; 1983 May; 29(5):828-31. PubMed ID: 6839460
[TBL] [Abstract][Full Text] [Related]
36. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
[TBL] [Abstract][Full Text] [Related]
37. Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.
Sato Y; Hanai J; Takasugi N; Takeda T
Tohoku J Exp Med; 1986 Oct; 150(2):169-74. PubMed ID: 3810642
[TBL] [Abstract][Full Text] [Related]
38. [Neuroblastoma in children: clinical and biological aspects. An experience of screening in France].
Mathieu P; Favrot M; Frappaz D; Chauvin F; Greffe J; Montegue A; Lacroix C; David L; Brunat-Mentigny M; Philip T
Ann Biol Clin (Paris); 1993; 51(7-8):665-88. PubMed ID: 8166384
[TBL] [Abstract][Full Text] [Related]
39. Creatinine related reference ranges for urinary homovanillic acid and vanillylmandelic acid at 6 months of age.
Cole M; Parker L; Craft AW; Bell S; Dale G; McGill AC; Seviour JA; Smith J
Arch Dis Child; 1993 Mar; 68(3):376-8. PubMed ID: 8466241
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
Zhang H; He X; Miao Q; Li L; Song J; Jiang X
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]